 |
Minimale Einzahlung $50 Exklusive Aktion |
Unser Ergebnis |
0% Kommission |
Are you looking to buy Bausch Health stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:BHC! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Bausch Health stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Durchschnittliches Volumen
4,42 Millionen Aktien
MARKTKAPPE
$10.10 billion
Börse
NYSE
Kaufen Sie diese Aktie!
|
NAME
|
TICKER
|
INDUSTRIE
|
SECTOR
|
VOLUME
|
KAUFEN SIE DIESE AKTIE JETZT
|
|---|---|---|---|---|---|
|
NYSE:BHC
|
Pharmazeutische Präparate
|
Medizinisch
|
32,858 shs
|
Below is a quick guide on how to buy NYSE:BHC stocks safe, fast and around the world in less than five minutes.
Schritt 1: Eröffnen Sie ein Konto bei eToro – eToro is the best broker to buy Bausch Health shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Schritt 2: Laden Sie Ihre ID hoch - Gemäß den KYC-Vorschriften wird eToro Sie bitten, eine Kopie Ihres Reisepasses oder Führerscheins hochzuladen.
Schritt 3: Geld einzahlen - Zahlen Sie etwas Geld auf Ihr neu eingerichtetes eToro Konto ein. Sie können zwischen Banküberweisung, E-Wallet, Debit-/Kreditkarte oder Paypal wählen.
Schritt 4: Buy Bausch Health – Search for “”NYSE:BHC”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Bausch Health stocks with 0% commission!.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
13 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Bausch Health Companies in the last year. There are currently 6 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Bausch Health Companies stock.
Wall Street analysts have given Bausch Health Companies a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Bausch Health Companies wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
2 |  | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
3 |  | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:BHC stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Bausch Health stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Bausch Health stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Da es sich bei eToro um eine regulierte Plattform handelt, müssen Sie das KYC-Verfahren abschließen. Dies ist gängige Praxis und dauert nur ein paar Minuten. Sie müssen einen Lichtbildausweis (Reisepass, Führerschein) und einen Adressnachweis (Stromrechnung, Kontoauszug) vorlegen.
Sobald Sie sich angemeldet und Ihr Konto verifiziert haben, müssen Sie Geld einzahlen. eToro akzeptiert Kredit-/Debitkarten, Banküberweisungen und auch E-Wallets. Was auch immer Sie bevorzugen, es wird etwas für Sie dabei sein.
Now that you’ve funded your eToro account, just type “NYSE:BHC stocks" in die Suchleiste am oberen Rand des Bildschirms ein und drücken Sie auf "Handeln".
All that’s left is to buy some NYSE:BHC stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NYSE:BHC is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Bausch Health stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Bausch Health Companies is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Bausch Health Companies.
Bausch Health Companies will be holding an earnings conference call on Wednesday, February 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
Bausch Health Companies Inc. (NYSE:BHC) issued its quarterly earnings results on Sunday, November, 8th. The company reported $1.32 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.02 by $0.30. The firm earned $2.14 billion during the quarter, compared to analyst estimates of $2.05 billion. Bausch Health Companies had a positive trailing twelve-month return on equity of 173.20% and a negative net margin of 23.92%. Bausch Health Companies’s revenue was down 3.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.21 EPS.
View Bausch Health Companies’ earnings history.
Bausch Health Companies’ stock was trading at $18.45 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BHC shares have increased by 55.0% and is now trading at $28.60.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:BHC stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mehr als 95% der Kundengelder werden offline, in kalten Lagern, aufbewahrt, was für jeden Broker, der Ihr Vermögen verwaltet, entscheidend ist. Unabhängig davon, wie sicher eine Plattform sein soll, empfehlen wir die Verwendung von 2FA, um eine zusätzliche Sicherheitsebene für Ihr Konto zu schaffen.
eToro bietet Nutzern eine Reihe von Funktionen, um so schnell wie möglich mit dem Investieren zu beginnen. Es gibt eine relativ einzigartige Funktion namens Copy Trading, mit der Sie ein passives Einkommen erzielen können, indem Sie erfahrene Händler spiegeln. So können Sie schnell Gewinne erzielen und erhalten ein besseres Verständnis für die Strategien, die von Profis verwendet werden. Außerdem können Sie bei eToro in verwaltete Portfolios investieren. Ein verwaltetes Portfolio besteht aus einer Vielzahl ähnlicher Vermögenswerte, die in Gruppen zusammengefasst sind. Wenn Sie bereits über Handelserfahrung verfügen, können Sie auch in andere Märkte als Aktien investieren, da eToro den Handel mit ETFs, Rohstoffen, Kryptowährungen und Indizes ermöglicht. Wenn Sie bereits außerhalb des Aktienmarktes investieren, kann dies sehr nützlich sein, da Sie so alle Ihre Investitionen an einem einzigen Ort verwalten können.
Bausch Health Companies updated its fourth quarter 2020 After-Hours earnings guidance on Tuesday, January, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.2 billion, compared to the consensus revenue estimate of $2.12 billion.
13 Wall Street analysts have issued 1-year price objectives for Bausch Health Companies’ stock. Their forecasts range from $17.00 to $50.00. On average, they expect Bausch Health Companies’ share price to reach $29.23 in the next year. This suggests a possible upside of 2.2% from the stock’s current price.
View analysts’ price targets for Bausch Health Companies or view top-rated stocks among Wall Street analysts.
CFDs sind komplexe Instrumente und bergen aufgrund der Hebelwirkung ein hohes Risiko, schnell Geld zu verlieren. 68% der Konten von Kleinanlegern verlieren Geld beim Handel mit CFDs bei diesem Anbieter. Sie sollten sich überlegen, ob Sie verstehen, wie CFDs funktionieren und ob Sie das hohe Risiko, Ihr Geld zu verlieren, eingehen können.
Bausch Health Companies saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 13,970,000 shares, a decline of 16.9% from the December 15th total of 16,810,000 shares. Based on an average daily trading volume, of 3,660,000 shares, the days-to-cover ratio is currently 3.8 days. Currently, 4.0% of the company’s stock are short sold.
View Bausch Health Companies’ Short Interest.
Bausch Health Companies’ management team includes the following people:
Mr. Joseph C. Papa, CEO & Chairman (Age 66, Pay $4.86M)
Mr. Paul S. Herendeen, Exec. VP & CFO (Age 65, Pay $2.75M)
Ms. Christina M. Ackermann, Exec. VP, Gen. Counsel & Head of Commercial Operations (Age 56, Pay $1.51M)
Mr. Thomas J. Appio, Pres & Co-Head Bausch + Lomb/International (Age 59, Pay $2.09M)
Mr. Osama A. Eldessouky, Sr. VP, Controller & Chief Accounting Officer (Age 49)
Dr. Robert F. Butz, VP of Medical & Scientific Affairs
Mr. Arthur J. Shannon, Sr. VP and Head of Investor Relations & Communications
Mr. Michael McMyne, VP of Sales
Ms. Stacey Williams, VP of Marketing
Ms. Kelly Webber, Sr. VP & Chief HR Officer
43 employees have rated Bausch Health Companies CEO Joseph C. Papa on Glassdoor.com. Joseph C. Papa has an approval rating of 97% among Bausch Health Companies’ employees. This puts Joseph C. Papa in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
Some companies that are related to Bausch Health Companies include BeiGene (BGNE), Alexion Pharmaceuticals (ALXN), Astellas Pharma (ALPMY), Shiseido (SSDOY), Takeda Pharmaceutical (TKPYY), Genmab A/S (GMAB), Genmab A/S (GNMSF), MERCK Kommanditgesellschaft auf Aktien (MKGAF), CureVac (CVAC), UCB (UCBJF), Catalent (CTLT), Alnylam Pharmaceuticals (ALNY), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX) and BioMarin Pharmaceutical (BMRN).
View all of BHC’s competitors.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
Based on aggregate information from Reportlab watchlists, some companies that other Bausch Health Companies investors own include Gilead Sciences (GILD), Micron Technology (MU), Constellation Software (CSU), Intact Financial (IFC), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Advanced Micro Devices (AMD) and Bank of America (BAC).
Bausch Health Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol “BHC.”
Bausch Health Companies’ stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (0.61%), FIL Ltd (0.42%), Swiss National Bank (0.36%), Private Management Group Inc. (0.31%), Sumitomo Mitsui Trust Holdings Inc. (0.27%) and Gamco Investors INC. ET AL (0.22%). Company insiders that own Bausch Health Companies stock include Christina Ackermann, Eschenbach Andrew C Von, Holdings LP Valueact, John Paulson, Joseph C Papa, Mark C Mckenna, Schutter Richard U De and William D Humphries.
View institutional ownership trends for Bausch Health Companies.
BHC stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Intact Investment Management Inc., Aperio Group LLC, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Gabelli Funds LLC, Swiss National Bank, Terril Brothers Inc., and Creative Planning.
View insider buying and selling activity for Bausch Health Companies or view top insider-selling stocks.
BHC stock was acquired by a variety of institutional investors in the last quarter, including Ieq Capital LLC, FIL Ltd, Parkside Investments LLC, Gamco Investors INC. ET AL, Paradigm Capital Management Inc. NY, M&G Investment Management Ltd., Kestra Advisory Services LLC, and Pendal Group Limited. Company insiders that have bought Bausch Health Companies stock in the last two years include Christina Ackermann, Eschenbach Andrew C Von, Holdings LP Valueact, John Paulson, Joseph C Papa, Schutter Richard U De, and William D Humphries.
View insider buying and selling activity for Bausch Health Companies or or view top insider-buying stocks.
Shares of BHC can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interaktive Makler Bewertung, eToro Überprüfung, DEGiro Rückblick, AvaTrade Bewertung, IG Markets Rückblick, IC Märkte Rückblick, CMC Markets Rückblick, Admiral Markets Rückblick und viele mehr. Lesen Sie eine der Bewertungen, um alles über den Broker zu erfahren, und beginnen Sie jetzt mit dem Kauf von Aktien.
Wir von Reportlab.org möchten sicherstellen, dass Sie alle wichtigen Informationen über Aktien kaufen. Wir bieten Ihnen die besten Leitfäden zum Thema Börse mit persönlichen Bewertungen, Hintergrundinformationen, Plattformbewertungen, Anleitungen und mehr. Möchten Sie weitere Informationen erhalten? Dann schauen Sie sich die OTC-Aktien, NASDAQ-Aktien, NYSE-Aktien, LON-Aktien, FRA-Aktien, ETR-Aktien, EPA-Bestände, TSX-Aktien oder Amex Aktien. Sie suchen nach detaillierteren Informationen wie 5g Vorräte, Biotech-Aktien, Goldvorräte und andere Informationen aus unserem Reportlab.
How to buy Bausch Health stocks?
The safest and easiest way to buy NYSE:BHC stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Die Eröffnung eines Kontos bei einem dieser Broker ist ein kluger Schachzug, denn sie sind seit mehr als 10 Jahren aktiv, sehr sicher in der Nutzung und bieten die beste Plattform für Anfänger und erfahrene Händler. Wenn Sie mehr erfahren möchten, dann empfehlen wir Ihnen, unseren eToro oder DeGiro Ratgeber.
Where to buy Bausch Health stock?
You will first want to find a licensed broker that supports Bausch Health stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:BHC stocks in a safe and complete environment.
Is NYSE:BHC stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:BHC stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Bausch Health stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:BHC is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Bausch Health stock.
How do you trade Bausch Health stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Bausch Health stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:BHC stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Bausch Health stock?
To sell your NYSE:BHC stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Bausch Health stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:BHC stock.
Stephen kennt sich gut mit Finanzprodukten aus und hat insbesondere eine große Leidenschaft für die Aktienmärkte und ihre Teilnehmer. Wir hoffen, dass die bereitgestellten Informationen Ihnen helfen werden. Ist Ihnen etwas nicht ganz klar? Bitte hinterlassen Sie Ihre Fragen oder Kommentare unten auf der Seite.
| Unser Ergebnis ★★★★★ | |
| Unser Ergebnis ★★★★★ | |
| Unser Ergebnis ★★★★★ |
Newsletter
Neueste Nachrichten
| |
Unser Ergebnis |
0% Kommission |
Alle EPA-Aktien Weitere Informationen EPA-Aktien Was ist die Pariser Börse (EPA)? Jetzt
Aktien & Krypto-Daten in Echtzeit
Benachrichtigungen, Tipps & Neuigkeiten
Beste Aktien & Krypto-Führer
Online Broker & Börse Bewertungen
Reportlab Finanzen ist eine rein informative Website und stellt in keinem Fall eine Anlageberatung dar. Alle Investitionen sind mit Risiken verbunden und Sie können Ihre gesamten Investitionen verlieren. Investieren Sie kein Geld, das Sie sich nicht leisten können, zu verlieren.
Reportlab Finanzen
38 Holburn Lane
Heckfield Green
IP21 0UB
Vereinigtes Königreich
Copyright © 2022 Reportlab.Finance | Alle Rechte vorbehalten.
